Why the study?
Recurrent acute pancreatitis poses a significant challenge in clinical management.
This case underscores the importance of recognizing the association between oral contraceptive pills, hypertriglyceridaemia, and recurrent pancreatitis in patients with metabolic syndrome.
Answers are grounded in this paper and cite their sources.
Pharmacological management alone succeeded in this recurrent pancreatitis case; leaves open whether it reliably substitutes for plasmapheresis.
Recurrent acute pancreatitis poses a significant challenge in clinical management. In this case, a young, obese woman with metabolic syndrome presented with her third episode of acute pancreatitis within a span of 4 months. Due to unavailability, plasmapheresis could not be performed, and the patient was managed solely with pharmacological therapy. Initial evaluation revealed abdominal pain, tenderness and elevated laboratory markers. CT scan findings indicated pancreatic and peripancreatic oedema. Further investigations highlighted the presence of hypertriglyceridaemia and hypocalcaemia. As the patient was using oral contraceptive pills (OCP), it was crucial to consider their potential role in causing hypertriglyceridaemia. Consequently, the patient was advised to discontinue OCP use. Despite the lack of plasmapheresis, intensive medical management, including medication and lifestyle modifications, showed positive results. This case underscores the importance of recognising the association between OCP, hypertriglyceridaemia and recurrent pancreatitis in patients with metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Thapa et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: